Zavegepant Nasal Spray for the Acute Treatment of Migraine With Aura and Without Aura: Pooled Results From 2 Randomized, Placebo-Controlled Clinical Trials

被引:0
|
作者
Smith, T. [1 ]
Pavlovic, J. [2 ]
Mullin, K. [3 ]
Joshi, S. [4 ]
Croop, R. [5 ]
Mosher, L. [5 ]
Lovegren, M. [6 ]
Forshaw, M. [6 ]
Lipton, R. [2 ]
机构
[1] Study Metrix Res, St Petersburg, FL USA
[2] Albert Einstein Coll Med, Bronx, NY USA
[3] New England Inst Neurol & Headache, Stamford, CT USA
[4] Community Neurosci Serv, Westborough, MA USA
[5] Pfizer Inc, New York, NY USA
[6] Biohaven Pharmaceut, New Haven, CT USA
来源
HEADACHE | 2023年 / 63卷
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P-212
引用
收藏
页码:182 / 183
页数:2
相关论文
共 50 条
  • [1] Zavegepant Nasal Spray for the Acute Treatment of Migraine With Aura and Without Aura: Pooled Results From 2 Randomized, Placebo-Controlled Clinical Trials
    Smith, Timothy
    Pavlovic, Jelena
    Mullin, Kathleen
    Joshi, Shivang
    Croop, Robert
    Madonia, Jennifer
    Mosher, Linda
    Lovegren, Meghan
    Forshaw, Micaela
    Lipton, Richard
    NEUROLOGY, 2023, 100 (17)
  • [2] Efficacy of Zavegepant Nasal Spray for the Acute Treatment of Migraine Based on Triptan Treatment Experience: Pooled Results From 2 Randomized, Placebo-Controlled Clinical Trials
    Joshi, Shivang
    Smith, Timothy
    Pavlovic, Jelena
    Mullin, Kathleen
    Croop, Robert
    Madonia, Jennifer
    Mosher, Linda
    Lovegren, Meghan
    Forshaw, Micaela
    Lipton, Richard
    NEUROLOGY, 2023, 100 (17)
  • [3] Zavegepant 10 mg Nasal Spray is Effective for the Acute Treatment of Migraine Regardless of Attack Frequency: Pooled Results From 2 Randomized, Placebo-Controlled Clinical Trials
    Pavlovic, J.
    Smith, T.
    Mullin, K.
    Joshi, S.
    Croop, R.
    Mosher, L.
    Lovegren, M.
    Forshaw, M.
    Lipton, R.
    HEADACHE, 2023, 63 : 182 - 182
  • [4] Zavegepant 10 mg Nasal Spray is Effective for the Acute Treatment of Migraine Regardless of Attack Frequency: Pooled Results From 2 Randomized, Placebo-Controlled Clinical Trials
    Pavlovic, Jelena
    Smith, Timothy
    Mullin, Kathleen
    Joshi, Shivang
    Croop, Robert
    Madonia, Jennifer
    Mosher, Linda
    Lovegren, Meghan
    Forshaw, Micaela
    Lipton, Richard
    NEUROLOGY, 2023, 100 (17)
  • [5] Efficacy of Zavegepant Nasal Spray for the Acute Treatment of Migraine Based on Triptan Treatment Experience: Pooled Results From 2 Randomized, Placebo- Controlled Clinical Trials
    Joshi, S.
    Smith, T.
    Pavlovic, J.
    Mullin, K.
    Croop, R.
    Mosher, L.
    Lovegren, M.
    Forshaw, M.
    Lipton, R.
    HEADACHE, 2023, 63 : 137 - 138
  • [6] Efficacy of topiramate for the prevention of migraine in patients reporting symptoms of aura or migraine without aura: Pooled data from 3 placebo-controlled trials
    Pascual, J.
    Silberstein, S.
    Mao, L.
    Greenberg, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 76 - 76
  • [7] Efficacy of topiramate for the prevention of migraine in patients reporting symptoms of aura or migraine without aura: Pooled data from three placebo-controlled trials
    Silberstein, S
    Pascual, J
    Mao, L
    Greenberg, S
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S88 - S88
  • [8] Efficacy of topiramate for the prevention of migraine in patients reporting symptoms of aura or migraine without aura: Pooled data from 3 placebo-controlled trials
    Silberstein, S
    Pascual, J
    Mao, L
    Greenberg, S
    HEADACHE, 2005, 45 (06): : 824 - 824
  • [9] Intravenous dipyrone in the acute treatment of migraine without aura and migraine with aura: A randomized, double blind, placebo controlled study
    Bigal, ME
    Bordini, CA
    Tepper, SJ
    Speciali, JG
    HEADACHE, 2002, 42 (09): : 862 - 871
  • [10] Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study
    Bigal, ME
    Bordini, CA
    Tepper, SJ
    Speciali, JG
    CEPHALALGIA, 2002, 22 (05) : 345 - 353